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Objectives. The aim of this study was to assess the national management and outcome of popliteal artery aneurysm
(PAA).
Methods. In the Swedish National Registry 717 primary operations for PAA on 571 patients were registered prospectively
between 1987 and 2002. 235 patients presented with acute ischemia.
Results. Median age was 70 for men and 75 for women. Immediate surgery was performed in 135 legs, including intra-
operative thrombolysis in 32 cases (Immediate Surgery Group, ISG). Pre-operative thrombolysis was performed in 100 legs,
followed by acute (24 hours, 41 legs) or elective (59 legs) surgery (Delayed Surgery Group, DSG). DSG had smaller PAA
(27 versus 37 mm, p< 0.0001) and were younger (67 versus 72 years, p< 0.001). Run-off was worse in DSG than in ISG
(p< 0.001) and improved in 87% after thrombolysis. Amputation-rate was 27% in the ISG and 7% in the DSG,
P< 0.0001. The ISG required fasciotomy in 30% compared to 11% of the DSG, p¼ 0.0001.
Conclusion. Patients in the ISG and DSG differed in their pre-operative characteristics and were selected to the treatment
modalities in a complex manner. Preoperative thrombolysis improves run-off.
Keywords: Popliteal artery aneurysm; Thrombosis; Acute ischemia; Thrombolytic therapy; Surgery.Introduction
Popliteal artery aneurysm (PAA) is the most common
peripheral aneurysm. The patients often have no
symptoms before onset of acute limb ischemia. Acute
surgery has been the preferred therapy, but the
outcome is associated with a high amputation rate
and reduced graft patency compared with elective
revascularization.1e4 The acute management of the
thrombosed PAA is a challenge even for an experi-
enced vascular surgeon.
The first administration of intra-arterial thrombo-
lytic agents for acute popliteal artery thrombosis was
reported in 1962 as an adjuvant therapy after surgical
thrombo-embolectomy with partial success.5 Over the
last four decades the technique of intra-arterial
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oped and the number of patients treated has increased.
Randomised trials have failed to demonstrate an ad-
vantage of thrombolysis over surgery.6e8 However,
many centres in Sweden, use thrombolysis as the pre-
ferred treatment of acute limb ischemia without neuro-
logical impairment.
The first thrombolytic treatment of a thrombosed
PAA was reported in 1984.9 Case reports, or small
series, reported improved results after intra-arterial
thrombolytic therapy.1,9e13 Since no randomised trial
has assessed the management of PAA optimal treat-
ment is controversial. The Swedish Vascular registry,
Swedvasc,14 has registered >90% of open and endo-
vascular procedures in Sweden since 1994, offering
a unique possibility to study PAA.
The aim of this study was to assess the outcome of
PAAwith acute ischemia in a population-based study.
A secondary aim was to study how the introduction
of intra-arterial thrombolytic therapy may have
changed the management of patents with PAA with
acute ischemia, and assess if the amputation rate
had changed.rved.
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From January 1987 until November 2002, 110.000 vas-
cular surgical procedures (both open and endovascu-
lar) were registered prospectively in the Swedvasc.
Among those, 1231 interventions for infra-inguinal
aneurysms were extracted. All 42 institutions per-
forming vascular surgery in Sweden participated,
supplying the investigators with 1160 complete
patient records (94.2%). The principal investigator
visited 27 hospitals where 988 records were analysed
in situ, during 2004. In the remaining 15 hospitals 172
records were photocopied.
We identified 743 legs operated on for PAA among
593 patients (Fig. 1). We have previously reported the
general epidemiological findings of this study, includ-
ing symptoms, presentation, the prevalence of multiple
aneurysms, risk-factors for amputation, time-trends
and survival.15 This paper focuses on the 235 legs in
229patients treated forPAAwith acute ischemia (Fig. 1).
In the Swedvasc protocol survival, complications,
patency, re-operations and amputations are registered
at 30 days and at one year. Data on amputations were
cross-checked against the complete patient records
including those from the orthopaedic department. In
January 2005 mortality data were cross-checked
against the national population registry, feasible since
every citizen in Sweden has a unique personal iden-
tity code. Three time-periods were analysed: 1987e
1993, 1994e1997 and 1998e2002.Run-off distal to the popliteal aneurysm was evalu-
ated by noting the number of patent crural vessels in
continuity from the popliteal artery to the ankle on
angiography. If the intervention was performed within
36 h after presentation it was defined as acute. An
operation performed >24 hours after completion of
thrombolytic therapy was defined as elective. The
thrombolysis was performed as a regional intra-arterial
catheter procedure in all patients.
The study was approved by all nine Regional
Ethics Committees in Sweden. According to the rules
of the Swedvasc every living patient must give
informed consent before registration is performed.
Statistics
Differences in proportions were evaluated using the
chi-square test for nominal variables and Kendall’s
tau-b test for ordinal variables. Student’s t-test was
used to evaluate differences in continuous variables.
When run-off was compared on the same patients
before and after thrombolysis Wilcoxon Signed Ranks
test was used. Risk-factors were evaluated with Rela-
tive Risk (RR) and 95% confidence intervals (CI).
Results
Among the 229 patients, 14 were woman (6.1%). Men
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divided into two groups. In the first group (100 legs,
43%) the leg was treated with pre-operative thrombo-
lysis followed either by acute (24 hours, 41 legs) or
elective (59 legs) delayed surgical treatment. This
group is designated the ‘‘Delayed Surgery Group’’
(DSG). The second group (135 legs) was operated on
directly and is designated the ‘‘Immediate Surgery
Group’’ (ISG). In this last group, 32 legs underwent
intraoperative thrombolysis. The use preoperative
thrombolysis increased over the three time-periods,
p< 0.001 (Table 1). There was also increased use of
perioperatively thrombolysis over time, p¼ 0.005.
In 16 patients (6.8%) the contra-lateral leg had un-
dergone previous surgery for PAA and among them
ten (63%) underwent delayed surgery. The size of
the PAA was measured in 144 legs. The PAAs in the
DSG were smaller than in the ISG, and the patients
in the ISG were older (Table 2).
Run-off before treatment (operation or thromboly-
sis) was evaluated with angiography in 124 patients
in the ISG and 84 patients in the DSG and was bet-
ter in the ISG, p< 0.001 (Table 3). In the ISG most
angiograms were performed on the operating table.
Pre-operative ankle-brachial index was available in
only 51% in the ISG (mean 0.13) and 44% in the
DSG (0.28).
The thrombolytic agents used were tPA (92 legs),
Urokinase (22), Streptokinase (14) or unknown (4).
Streptokinase and Urokinase were used mostly in
the early part of the study-period. No serious side-
effect of thrombolysis, such as serious bleeding or
stroke, was registered neither in the Swedvasc, nor
in the patient-records, in any patient.
The duration of pre-operative thrombolysis was
a median of 23.7 hours (range 0.5e75). The delayed
surgery was either performed acutely (24 hours) or
electively (>24 hours). In the acutely operated group
(41 legs), 93% were operated on within 8 hours. The
duration of surgical delay, from preoperative throm-
bolysis until operation in the elective group was a
median of 8 days (range: 1e90). In the 32 legs that
underwent intraoperatively thrombolysis the duration
was a median of 0.5 hours (range: 0.25e10).Eur J Vasc Endovasc Surg Vol 33, June 2007The effect of the preoperative thrombolysis was
evaluated by the change in run-off. It was possible
to review the angiograms both before and after throm-
bolysis in 84 legs (84%). The run-off was improved in
87% and unchanged in 13%. All amputations occurred
among the legs with an angiogram without visible
vessels before thrombolysis. In two legs an early am-
putation occurred despite improved run-off, in those
two legs no fasciotomy was performed. The four pa-
tients who had no visible crural vessels either before
or after thrombolysis were all amputated within one
week.
In the ISG 125 legs were operated on with a medial
and four with a posterior approach. In the DSG 80
legs were operated on with a medial, eleven with
a posterior and seven with endovascular approach.
Eight legs were operated on with other miscellaneous
techniques. Vein-grafts were used more often in the
DSG (93%) than in the ISG (70%).
The one year amputation-rate was 27% in the ISG
and 7% in the DSG, p< 0.0001 (Table 2). There was
no difference in amputation-rate between the intra-
operatively thrombolysed and the group that was op-
erated on only. In the DSG there was a non-significant
trend towards a lower amputation-rate (5.1%) among
those operated on electively after completion of
thrombolysis compared to those who were operated
on emergently (9.8%) (p¼ 0.14). When the three
time-periods were compared for all legs, a trend
towards decreasing amputation-rates was observed,
p¼ 0.06 (Table 1).
Fasciotomy (primary or secondary) was performed
in 30% in the ISG and in 11% in the DSG, p< 0.0001.
Fasciotomy rates increased in the ISG over time,
p¼ 0.003, but not in the DSG (Table 4). Amputation
Table 2. Difference between the delayed surgery group (DSG) and
the immediate surgery group (ISG) regarding age, aneurysm size
and amputation-rate
DSG ISG p
Size (mean) 27 mm 37 mm <0.001
Age (mean) 66.8 year 71.6 year <0.001
Amputation 7 % 27 % <0.001
The size of the PAA was measured in 144 legs.Table 1. Time-trends. Amputation-rates, and frequency of amputation without prior fasciotomy, during three time periods
1987e1993 1994e1997 1998e2002 p
Group ISG DSG ISG DSG ISG DSG <0.001
N legs 41 9 58 40 36 51
Amp./N legs 14/50 (28%) 17/98 (17%) 12/87 (14%) ¼0.06
Amp. without
fasciotomy (% of amp legs)
11 (79%) 10 (59%) 4 (33%) ¼0.02
ISG: Immediate Surgery Group; DSG: Delayed Surgery Group.
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(Table 1).
Discussion
This study was based on prospective data, reported
from the vascular institutions in Sweden and supple-
mented with a retrospective review of the patient
records at the local institutions. We were supplied
with complete records in 94% of the procedures. The
validity of the reporting of cases is further supported
by the fact that 15e38% more patients were recorded
in the Swedvasc registry than to the HDR, used for
reimbursement. The patients are often operated on
bilaterally, and we studied the registration of the
contra-lateral operation for validation purposes. In
all, 141 of the 146 contra lateral procedures (97%)
had been reported to the registry. Missing patients
or operated legs seem to be uncommon.
The Swedvasc registry has been extensively vali-
dated previously. The validation procedures have
shown that core surgery, such as AAA-repair,16,17
carotid artery thrombendarterectomy,18,19 and femoro-
popliteal17 bypass are reported in more than 90% and
with great validity of data. Endovascular procedures
are reported with less validity. We conclude that treat-
ment for acute PAA in this respect can be regarded as
core surgery. It is important to evaluate the validity of
each Vascular Registry independently. The fact that
one National Vascular Registry lacks validity does not
have general implications.20
The principal goal in the treatment of an ischemic
limb is rapid restoration of blood flow to the ischemic
limb before the occurrence of irreversible damage,
Table 3. Run-off before treatment in ISG and DSG
Acute treatment of 208 legs
DSG ISG
Number % Number %
No open artery 64 76 46 37
Isolated crural artery 16 19 19 15
Poplitealarteryþ1e3 crural vessels 4 5 59 48
Kendall’s tau-b p< 0.001. Of the 235 investigated legs, 208 had pre-
operative angiography.thus preventing amputation. Thrombolytic therapy,
as an initial therapy followedby surgical repair, was as-
sociated with a lower risk of amputation in this study.
However, patients in the DSG were younger and
had smaller PAA. On the other hand they had signif-
icantly worse run-off prior to therapy. Some patients
may have been selected to ISG because they had
good preoperative run-off that did not require throm-
bolytic therapy. Unfortunately we lack data on the
severity of ischemia, such as sensory and motor func-
tion loss. We also lack data on contra-indications for
thrombolysis. The selection process to the two treat-
ment modalities is complex, we can only conclude
that the two patient groups are very different in their
pre-operative characteristics.
Despite the fact that definitive treatment was de-
layed, and their run-off prior to treatment was worse,
the patients in the DSG were treated with fasciotomy
less frequently than patients in the ISG. Previous stud-
ies have shown a better outcome for elective than
emergent PAA21,22 and an association with better run-
off. In this study a change from acute to elective treat-
ment was observed in 59% of the patients treated with
preoperative thrombolysis. This shift to elective sur-
gery may explain the improved outcome. In the
DSG vein grafts were used more frequently possibly
explaining the improved outcome. The patients in
the DSG who were treated with acute operations after
thrombolysis had an intermediate outcome: Better
than the ISG, but worse than those who underwent
an elective operation after thrombolysis. This differ-
ence may be related to the fact that 87% of the legs im-
proved their runoff after preoperative thrombolysis.
Furthermore, legs without improvement of run-off
were those amputated in the DSG.
Thrombolysis is known to have a risk of hemor-
rhagic complications,8,23 but in this study no such
side-effects occurred. It seems reasonable to conclude
that thrombolytic therapy in this patient group is
safe, given that well-known contraindications are
respected.11,24,25 Many vascular surgeons believe that
pre-operative thrombolysis is contra-indicated in pa-
tients with PAA, mainly due to the risk of embolism
into the distal vessels. Although we are unable toTable 4. Time trends, fasciotomy
1987e1993 1994e1997 1998e2002 p
Group ISG DSG ISG DSG ISG DSG
N legs 41 9 58 40 36 51
Fasciotomy in ISG 6 (15%) 18 (31%) 16 (44%) ¼0.003
Fasciotomy in DSG 1 (11%) 5 (13%) 5 (10%) ¼0.75
ISG: Immediate Surgery Group; DSG: Delayed Surgery Group.Eur J Vasc Endovasc Surg Vol 33, June 2007
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a better outcome, due to the limitations of the study
design discussed above, we can conclude that this
treatment option is safe and results in improved
run-off.
We observed that fasciotomy was more frequent in
the ISG, and increasedover time in this sub-group.Dur-
ing the first studied time-period amputated legs had
frequently not undergone fasciotomy prior to amputa-
tion, which was less frequent during the last period.
This suggests that some amputations before 1994 may
have been avoidable with timely fasciotomy.
The studied period coincides with a stage of in-
creased specialization. Early on many patients were
treated by general surgeons, later by vascular specialists
trained in evaluating and treating acute limb ischemia.
Conclusions
The patients in the immediate and delayed surgical
groups differed in their pre-operative characteristics
and were selected to the different treatment modali-
ties in a complex manner. Intra-arterial preoperative
thrombolysis improved runoff in this sub-group. A
trend towards a decreased amputation- rate during
the 15 year study-period was associated with in-
creased use of pre-operative thrombolysis and
fasciotomy, although a cause effect cannot be veri-
fied. This time-trend may relate to the availability
of vascular specialists.
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